Epidermal Growth Factor Receptor Ectodomain in the Urine of Patients with Squamous Cell Carcinoma

Lois M. Witters, Elizabeth M. Curley, Rakesh Kumar, Vernon Chinchilli, Jeanne P. Harvey, Victoria Crebbin, Harold Harvey, Allan Lipton

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In this study we determined the levels of the epidermal growth factor receptor (EGFR) in the urine of patients with squamous cell carcinoma compared to levels in the urine of normal volunteers and patients with nonsquamous cell carcinoma. A 24-h urine specimen was collected from 50 normal volunteers, 50 patients with nonsquamous cell carcinoma, and 42 patients with squamous cell carcinoma. An ELISA using mAbs to the external domain of the EGFR was used to measure levels of the receptor in the urine samples. Measurement of the EGFR ectodomain in the 24-h urine specimens showed detectable levels in 15 (36%) of 42 squamous cell carcinoma patients compared to 3 (6%) of 50 controls and 8 (16%) of 50 nonsquamous patients. It was also observed that 10 (53%) of 19 patients with metastatic squamous cell carcinoma had detectable EGFR ectodomain levels compared to 5 (22%) of 23 squamous cell patients with localized disease. Thus, we concluded that the EGFR ectodomain was detectable in the urine in a significantly higher number of patients with squamous cell carcinoma than normal volunteers or patients with nonsquamous cell carcinoma.

Original languageEnglish (US)
Pages (from-to)551-557
Number of pages7
JournalClinical Cancer Research
Volume1
Issue number5
StatePublished - May 1 1995

Fingerprint

Epidermal Growth Factor Receptor
Squamous Cell Carcinoma
Urine
Healthy Volunteers
Carcinoma
Epithelial Cells
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Witters, Lois M. ; Curley, Elizabeth M. ; Kumar, Rakesh ; Chinchilli, Vernon ; Harvey, Jeanne P. ; Crebbin, Victoria ; Harvey, Harold ; Lipton, Allan. / Epidermal Growth Factor Receptor Ectodomain in the Urine of Patients with Squamous Cell Carcinoma. In: Clinical Cancer Research. 1995 ; Vol. 1, No. 5. pp. 551-557.
@article{90e887c5393042cdbebafc3a27f3f46b,
title = "Epidermal Growth Factor Receptor Ectodomain in the Urine of Patients with Squamous Cell Carcinoma",
abstract = "In this study we determined the levels of the epidermal growth factor receptor (EGFR) in the urine of patients with squamous cell carcinoma compared to levels in the urine of normal volunteers and patients with nonsquamous cell carcinoma. A 24-h urine specimen was collected from 50 normal volunteers, 50 patients with nonsquamous cell carcinoma, and 42 patients with squamous cell carcinoma. An ELISA using mAbs to the external domain of the EGFR was used to measure levels of the receptor in the urine samples. Measurement of the EGFR ectodomain in the 24-h urine specimens showed detectable levels in 15 (36{\%}) of 42 squamous cell carcinoma patients compared to 3 (6{\%}) of 50 controls and 8 (16{\%}) of 50 nonsquamous patients. It was also observed that 10 (53{\%}) of 19 patients with metastatic squamous cell carcinoma had detectable EGFR ectodomain levels compared to 5 (22{\%}) of 23 squamous cell patients with localized disease. Thus, we concluded that the EGFR ectodomain was detectable in the urine in a significantly higher number of patients with squamous cell carcinoma than normal volunteers or patients with nonsquamous cell carcinoma.",
author = "Witters, {Lois M.} and Curley, {Elizabeth M.} and Rakesh Kumar and Vernon Chinchilli and Harvey, {Jeanne P.} and Victoria Crebbin and Harold Harvey and Allan Lipton",
year = "1995",
month = "5",
day = "1",
language = "English (US)",
volume = "1",
pages = "551--557",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

Epidermal Growth Factor Receptor Ectodomain in the Urine of Patients with Squamous Cell Carcinoma. / Witters, Lois M.; Curley, Elizabeth M.; Kumar, Rakesh; Chinchilli, Vernon; Harvey, Jeanne P.; Crebbin, Victoria; Harvey, Harold; Lipton, Allan.

In: Clinical Cancer Research, Vol. 1, No. 5, 01.05.1995, p. 551-557.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epidermal Growth Factor Receptor Ectodomain in the Urine of Patients with Squamous Cell Carcinoma

AU - Witters, Lois M.

AU - Curley, Elizabeth M.

AU - Kumar, Rakesh

AU - Chinchilli, Vernon

AU - Harvey, Jeanne P.

AU - Crebbin, Victoria

AU - Harvey, Harold

AU - Lipton, Allan

PY - 1995/5/1

Y1 - 1995/5/1

N2 - In this study we determined the levels of the epidermal growth factor receptor (EGFR) in the urine of patients with squamous cell carcinoma compared to levels in the urine of normal volunteers and patients with nonsquamous cell carcinoma. A 24-h urine specimen was collected from 50 normal volunteers, 50 patients with nonsquamous cell carcinoma, and 42 patients with squamous cell carcinoma. An ELISA using mAbs to the external domain of the EGFR was used to measure levels of the receptor in the urine samples. Measurement of the EGFR ectodomain in the 24-h urine specimens showed detectable levels in 15 (36%) of 42 squamous cell carcinoma patients compared to 3 (6%) of 50 controls and 8 (16%) of 50 nonsquamous patients. It was also observed that 10 (53%) of 19 patients with metastatic squamous cell carcinoma had detectable EGFR ectodomain levels compared to 5 (22%) of 23 squamous cell patients with localized disease. Thus, we concluded that the EGFR ectodomain was detectable in the urine in a significantly higher number of patients with squamous cell carcinoma than normal volunteers or patients with nonsquamous cell carcinoma.

AB - In this study we determined the levels of the epidermal growth factor receptor (EGFR) in the urine of patients with squamous cell carcinoma compared to levels in the urine of normal volunteers and patients with nonsquamous cell carcinoma. A 24-h urine specimen was collected from 50 normal volunteers, 50 patients with nonsquamous cell carcinoma, and 42 patients with squamous cell carcinoma. An ELISA using mAbs to the external domain of the EGFR was used to measure levels of the receptor in the urine samples. Measurement of the EGFR ectodomain in the 24-h urine specimens showed detectable levels in 15 (36%) of 42 squamous cell carcinoma patients compared to 3 (6%) of 50 controls and 8 (16%) of 50 nonsquamous patients. It was also observed that 10 (53%) of 19 patients with metastatic squamous cell carcinoma had detectable EGFR ectodomain levels compared to 5 (22%) of 23 squamous cell patients with localized disease. Thus, we concluded that the EGFR ectodomain was detectable in the urine in a significantly higher number of patients with squamous cell carcinoma than normal volunteers or patients with nonsquamous cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0029037693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029037693&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 551

EP - 557

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -